Buying Guides

Ruxolitinib Buy Online: Jakafi/Jakavi 5mg Tablets | GLT

To buy ruxolitinib online, you are looking for the JAK1/JAK2 inhibitor sold as Jakafi in the United States and as Jakavi (捷恪卫) in China and Europe. GLT supplies the Jakafi/Jakavi (Ruxolitinib) 5mg tablets, a Novartis-presented product for myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD), at an indicative price of around $400 for a 5mg × 60-tablet pack.

What Is Ruxolitinib and What Is It Used For?

Ruxolitinib is a JAK1/JAK2 tyrosine kinase inhibitor, an oral targeted therapy that blocks the Janus kinase signaling pathway that drives overactive blood-cell production in several rare blood disorders. It is not a conventional chemotherapy drug; it works by selectively inhibiting the two Janus kinase enzymes that relay the abnormal growth signals behind these conditions, which is why it both shrinks the spleen and relieves the systemic symptoms of the disease.

The molecule was discovered and developed by Incyte, which markets it as Jakafi in the United States; Novartis holds the exclusive commercialization rights outside the US and sells the same medicine as Jakavi (捷恪卫) in China and Europe. Whether the box reads Jakafi or Jakavi, the active ingredient is the same ruxolitinib phosphate.

Ruxolitinib is approved for three main indications. The first is myelofibrosis (MF) — intermediate- or high-risk primary myelofibrosis, post-polycythemia-vera myelofibrosis, and post-essential-thrombocythemia myelofibrosis — where it reduces an enlarged spleen and relieves symptoms such as fatigue, night sweats, itching and early satiety. The second is polycythemia vera (PV) in adults who did not respond well enough to, or could not tolerate, hydroxyurea. The third is graft-versus-host disease (GVHD) — steroid-refractory acute GVHD in adults and children aged 12 and older, with chronic GVHD after failure of one or two lines of systemic therapy approved as a fourth indication in the US label. Each indication carries its own dosing and monitoring requirements, so treatment always sits under a hematologist's supervision.

Ruxolitinib Tablets 5mg: Strengths and Dosing

Ruxolitinib is an oral tablet taken twice daily, with or without food. The immediate-release tablet strengths are 5 mg, 10 mg, 15 mg, 20 mg and 25 mg, and the starting dose is set by the treating doctor based on the indication and the patient's baseline platelet count.

For myelofibrosis, the starting dose follows a platelet-count ladder: patients with platelets above 200 × 10⁹/L start at 20 mg twice daily, those between 100 and 200 × 10⁹/L start at 15 mg twice daily, and those between 50 and 100 × 10⁹/L start at the 5 mg strength twice daily. For acute GVHD the starting dose is also 5 mg twice daily, and for polycythemia vera it is 10 mg twice daily. This is why the ruxolitinib 5 mg tablet is such a common search and such a common starting point for treatment — it is the entry strength for lower-platelet myelofibrosis and for acute GVHD. Dose is then titrated up under regular blood-count monitoring, never self-adjusted.

If you searched "ruxolitinib tablets 5mg" or "ruxolitinib 5 mg," you are looking at the same starter strength — a 5 mg film-coated tablet — that physicians prescribe most often at the beginning of therapy. The product GLT supplies is the 5 mg × 60-tablet pack, a standard one-month supply for twice-daily dosing.

Jakafi 5mg vs Jakavi 5mg: The Same Medicine, Two Brand Names

One of the most common points of confusion is the relationship between Jakafi and Jakavi, and both appear in searches alongside "novartis." The facts are straightforward:

  • Jakafi is the US brand name, owned and marketed by Incyte, the originator of ruxolitinib.
  • Jakavi (捷恪卫) is the brand name used in China, Europe and most other markets, marketed by Novartis under license from Incyte.
  • Novartis is the commercial partner, not the originator — the molecule ruxolitinib is Incyte's discovery.

So "jakafi 5mg", "jakavi 5mg" and "ruxolitinib novartis" all point to the same active therapy. The only real difference is which regional brand label is printed on the carton. You can review the full prescribing information for the US brand on the NIH DailyMed entry for ruxolitinib, and the official indication details on the Jakafi product site.

Ruxolitinib Manufacturer: Incyte (Originator) and Novartis (China/EU)

When buyers search "ruxolitinib manufacturer china," they usually mean one of two things: where the originator molecule comes from, and where the medicine they can actually obtain is sourced. The originator is Incyte, which received initial US approval in 2011. The version approved and sold in China is presented by Novartis as Jakavi (捷恪卫), with China approval granted in 2017 and inclusion in China's national reimbursement drug list. The medicine GLT ships is the Novartis China presentation with mainland labeling, supplied through a China-based service — which is what "manufacturer china" refers to in practical sourcing terms for international buyers.

Safety, Monitoring and Why a Doctor's Supervision Matters

Ruxolitinib is not a medicine to self-dose. It can cause low blood cell counts — thrombocytopenia, anemia and neutropenia — so patients need a complete blood count before starting and regular monitoring throughout treatment, with doses reduced or interrupted based on the results. It also carries a risk of serious infection, and stopping treatment abruptly can cause a return of myelofibrosis symptoms. These are exactly the reasons the medicine is prescription-only and must be managed by a hematologist rather than ordered casually online.

For international buyers, this has a practical implication: the value of a supplier is not just the price, but whether the product is genuine, properly stored and traceable. A legitimate inquiry process that confirms indication, strength and batch documentation is a sign of a responsible source — not an obstacle.

Why Source Ruxolitinib from China Through GLT

China is a major regulated market for ruxolitinib, and the Novartis Jakavi presentation approved there is the same originator molecule sold in Europe. For buyers in countries where the medicine is expensive, delayed or difficult to access, a China-based service offers a practical route to the genuine Novartis presentation with mainland labeling and batch traceability. GLT — GIVE LIFE TIME LIMITED — specializes in exactly this: sourcing China-approved originator and branded medicines and shipping them worldwide through a verified inquiry process, with the documentation to match.

How to Verify a Genuine Ruxolitinib Supply

Because ruxolitinib is a high-value prescription medicine, verifying authenticity before buying is not optional. Three checks protect you when you buy ruxolitinib online:

  • Check the brand and batch — a genuine China presentation carries the Jakavi (捷恪卫) brand and mainland batch numbers, which can be traced against the NMPA registry.
  • Confirm the strength — the 5 mg tablet is a specific strength with distinct packaging; a supplier that cannot tell you the exact strength and pack size should be avoided.
  • Confirm storage and cold-chain documentation — proper storage and batch-level traceability are the difference between a pharmacy-grade supply and an unverified repack.

GLT provides batch-level documentation so the product can be traced back to its source, and follows appropriate storage during dispatch.

Where to Buy Ruxolitinib for Sale Online

If your search is "ruxolitinib for sale" or "ruxolitinib buy online," the key question is sourcing a genuine, properly stored product rather than an unverified repack. Ruxolitinib is a prescription medicine, so GLT follows an inquiry process rather than a self-service cart:

  1. Confirm the indication and the appropriate starting dose with your hematologist.
  2. Send your inquiry via WhatsApp or email with the strength and quantity you need.
  3. Our team verifies availability and batch details, then arranges dispatch with appropriate storage.

As an indicative guide, GLT pricing for the Jakafi/Jakavi (Ruxolitinib) 5mg tablets is around $400 for a 5mg × 60-tablet pack. For a broader look at sourcing medicines from China, see our Mounjaro China buying guide, and browse our other buying guides for related oncology and hematology medicines.

Questions or ready to order? Contact us on WhatsApp +86 15234153837 or email [email protected].

Frequently Asked Questions

What is ruxolitinib used for?

Ruxolitinib is a JAK1/JAK2 inhibitor used to treat myelofibrosis (MF), polycythemia vera (PV) after hydroxyurea failure, and graft-versus-host disease (GVHD). It reduces spleen size and relieves disease-related symptoms.

Is Jakafi the same as Jakavi?

Yes. Jakafi is the US brand name from Incyte, and Jakavi (捷恪卫) is the China and Europe brand name marketed by Novartis. Both contain the same active ingredient, ruxolitinib.

What strength does ruxolitinib come in?

Ruxolitinib tablets come in 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. The 5 mg tablet is the common starting strength for lower-platelet myelofibrosis and acute GVHD.

Is Novartis the manufacturer of ruxolitinib?

Novartis is the commercial partner outside the US, not the originator. Ruxolitinib was discovered by Incyte, which markets it as Jakafi in the US; Novartis markets the same medicine as Jakavi in China and Europe.

How much does ruxolitinib 5mg cost?

GLT's indicative price for the Jakafi/Jakavi ruxolitinib 5mg tablets is around $400 for a 5mg × 60-tablet pack. Contact us for a current quote for your strength and quantity.

Do I need a prescription to buy ruxolitinib online?

Ruxolitinib is a prescription medicine. GLT's inquiry process includes verification before dispatch — contact us via WhatsApp or email, and our team will guide you through what is required.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Ruxolitinib (Jakafi/Jakavi) is a prescription medicine; always consult a qualified hematologist or healthcare professional about diagnosis, dosage and treatment. Prices are indicative and subject to confirmation at inquiry.

Ruxolitinib Cream Vitiligo Buy Online: Opzelura/Lumirix | GLT
Mounjaro Chinese Name: 穆峰达 (Tirzepatide) & How to Buy | GLT